Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Research Article

Effect of Novel Laser Shoe Photobiomodulation on Neuropathic Pain and Plantar Pressure Profile in Type 2 Diabetes Mellitus with Peripheral Neuropathy

In Press, (this is not the final "Version of Record"). Available online 13 February, 2024
Author(s): G. Arun Maiya*, Radhika Aditya Jadhav, Hrishikesh Yadav K., Manjunatha Hande H., Harishchandra Hebbar and Karthik Mohan
Published on: 13 February, 2024

Article ID: e130224226913

DOI: 10.2174/0115733998244000231106040749

Price: $95

Abstract

Background: Photobiomodulation (PBM) or Low-level laser is used to treat diabetic foot complications. The existing method of laser application to the foot did not cover the foot's entire area to improve the foot's microcirculation. Therefore, we have developed a cost-effective Special LASER Shoe device, focusing exclusively on the entire foot region to manage neuropathic pain and other symptoms in individuals with type 2 diabetes mellitus.

Objective: The main objective of the present study was to evaluate the effect of this newly developed special laser shoe PBM on neuropathic pain and plantar pressure profile in individuals with type 2 diabetes mellitus with neuropathy.

Methods: We included 60 participants with diabetic peripheral neuropathy of both genders and age more than 20 years. Participants were treated with PBM by a specially designed novel Laser Shoe. Outcomes were clinical variables like Vibration Perception Threshold (VPT), Visual Analogue Scale (VAS), Michigan neuropathy screening instrument A&B, Ankle-Brachial Index (ABI), and Static dynamic gait parameters.

Results: Participants were with an average age of 62, and the average duration of diabetes was 11 years. Analysis showed a significant difference in VPT, VAS, Michigan neuropathic screening inventory, and ankle-brachial index. (P < 0.05).

Conclusion: We conclude that Novel laser shoe photobiomodulation using 'Laser Shoe' effectively reduces peripheral neuropathic pain. It is also effective in reducing average and maximum plantar pressure. Reduction in neuropathic pain and improvement in plantar pressure distribution can reduce further complications.

[1]
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388(10053): 1659-724.
[http://dx.doi.org/10.1016/S0140-6736(16)31679-8]
[2]
Anjana RM, Deepa M, Pradeepa R, et al. Prevalence of diabetes and prediabetes in 15 states of India: Results from the ICMR–INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol 2017; 5(8): 585-96.
[http://dx.doi.org/10.1016/S2213-8587(17)30174-2] [PMID: 28601585]
[3]
Vibha SP, Kulkarni MM, Kirthinath Ballala AB, Kamath A, Maiya GA. Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus. BMC Endocr Disord 2018; 18(1): 43.
[http://dx.doi.org/10.1186/s12902-018-0270-2] [PMID: 29940924]
[4]
Maiya AG, Gundmi S, Matpady P, et al. Prevalence of foot complications in people with type 2 diabetes mellitus: A community-based survey in rural udupi. Int J Low Extrem Wounds 2018; 17(3): 169-75.
[http://dx.doi.org/10.1177/1534734618791853] [PMID: 30111220]
[5]
Yamany AA, Sayed HM. Effect of low level laser therapy on neurovascular function of diabetic peripheral neuropathy. J Adv Res 2012; 3(1): 21-8.
[http://dx.doi.org/10.1016/j.jare.2011.02.009]
[6]
Hazari A, Maiya AG, Shivashankara KN. Foot kinetic and kinematic profile in type 2 diabetes mellitus with peripheral neuropathy: A hospital-based study from south India. J Am Podiatr Med Assoc 2019; 109(1): 36-49.
[http://dx.doi.org/10.7547/17-059] [PMID: 29389217]
[7]
Fernando ME, Crowther RG, Lazzarini PA, et al. Plantar pressures are higher in cases with diabetic foot ulcers compared to controls despite a longer stance phase duration. BMC Endocr Disord 2016; 16(1): 51.
[http://dx.doi.org/10.1186/s12902-016-0131-9] [PMID: 27629263]
[8]
Mohamed RA, Abdallah GA, Abdeen HA, Nassif AA. Influence of low level laser therapy versus pulsed electromagnetic field on diabetic peripheral neuropathy. Phys Ther Rehabil 2017; 4(1): 17.
[http://dx.doi.org/10.7243/2055-2386-4-17]
[9]
Cg SK, Maiya AG, Hande HM, Vidyasagar S, Rao K, Rajagopal KV. Efficacy of low level laser therapy on painful diabetic peripheral neuropathy. Laser Ther 2015; 24(3): 195-200.
[http://dx.doi.org/10.5978/islsm.15-OR-12] [PMID: 26557734]
[10]
M A, Ummer V S, Maiya AG, Hande M. Low level laser therapy for the patients with painful diabetic peripheral neuropathy - A systematic review. Diabetes Metab Syndr 2019; 13(4): 2667-70.
[http://dx.doi.org/10.1016/j.dsx.2019.07.035] [PMID: 31405692]
[11]
Jannu C, Chandupatla VD, Babu PS, Puchchakayala G. Effect of low level laser therapy in the management of diabetic neuropathic pain: A systematic review and meta analysis. Biomed 2018; 38(4): 465-70.
[12]
Carmeliet P. Blood vessels and nerves: Common signals, pathways and diseases. Nat Rev Genet 2003; 4(9): 710-20.
[http://dx.doi.org/10.1038/nrg1158] [PMID: 12951572]
[13]
Funk JO, Kruse A, Neustock P, Kirchner H. Helium-neon laser irradiation induces effects on cytokine production at the protein and the mRNA level. Exp Dermatol 1993; 2(2): 75-83.
[http://dx.doi.org/10.1111/j.1600-0625.1993.tb00012.x] [PMID: 7908841]
[14]
Rochkind S, Ouaknine GE. New trend in neuroscience: Low-power laser effect on peripheral and central nervous system (basic science, preclinical and clinical studies). Neurol Res 1992; 14(1): 2-11.
[http://dx.doi.org/10.1080/01616412.1992.11740003] [PMID: 1351254]
[15]
Karu T, Pyatibrat L, Kalendo G. Irradiation with HeNe laser increases ATP level in cells cultivated in vitro. J Photochem Photobiol B 1995; 27(3): 219-23.
[http://dx.doi.org/10.1016/1011-1344(94)07078-3] [PMID: 7769534]
[16]
Ruh AC, Frigo L, Cavalcanti MFXB, et al. Laser photobiomodulation in pressure ulcer healing of human diabetic patients: Gene expression analysis of inflammatory biochemical markers. Lasers Med Sci 2018; 33(1): 165-71.
[http://dx.doi.org/10.1007/s10103-017-2384-6] [PMID: 29181642]
[17]
Tullberg M, Alstergren PJ, Ernberg MM. Effects of low-power laser exposure on masseter muscle pain and microcirculation. Pain 2003; 105(1): 89-96.
[http://dx.doi.org/10.1016/S0304-3959(03)00166-0] [PMID: 14499424]
[18]
Hak-Chol R, Sin-Hyok H, Chol-Jun H. Plantar pressure changes in diabetic peripheral neuropathy. Menoufia Med J 2019; 32(1): 1214-6.
[http://dx.doi.org/10.4103/mmj.mmj]
[19]
Papanas N, Maltezos E. The diabetic foot: A global threat and a huge challenge for Greece. Hippokratia 2009; 13(4): 199-204.
[PMID: 20011082]
[20]
Rochkind S, Geuna S, Shainberg A. Chapter 25: Phototherapy in peripheral nerve injury: Effects on muscle preservation and nerve regeneration. Int Rev Neurobiol 2009; 87(C): 445-64.
[http://dx.doi.org/10.1016/S0074-7742(09)87025-6] [PMID: 19682654]
[21]
Barbosa RI, Marcolino AM, de Jesus Guirro RR, Mazzer N, Barbieri CH, de Cássia Registro Fonseca M. Comparative effects of wavelengths of low-power laser in regeneration of sciatic nerve in rats following crushing lesion. Lasers Med Sci 2010; 25(3): 423-30.
[http://dx.doi.org/10.1007/s10103-009-0750-8] [PMID: 20135336]
[22]
Hamblin MR, Carroll JD, de Freitas LF, Huang Y-Y, Ferraresi C. Low-Level Light Therapy: Photobiomodulation. Bellingham: SPIE Press 2018.
[http://dx.doi.org/10.1117/3.2295638]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy